Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host its 2025 Annual Meeting ...

Continued growth and solid EBITDA margin Columbus' revenue amounted to DKK 1,659m in 2024, corresponding to an increase of 8%. Organically ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

Kansans are vital in ensuring accurate National Weather Service warnings during severe weather. Whether it's tornadoes, high ...

Operator Greetings and welcome to the UiPath fourth quarter 2025 earnings conference call. At this time, all participants are ...

LexinFintech's recent profit spike is driven by changes in financial guarantee derivatives, while operating costs outpace ...

Q4 2024 Results Conference Call March 12, 2025 5:00 PM ETCompany ParticipantsJenny Mitchell - VP, Finance Strategy and ...

The Carson City Cultural Commission is meeting Monday to elect chair and vice chair of the commission and to review ...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...

Mayor Chris Leusner continued a township tradition by delivering his annual State of the Township address to the Middle ...

As Trump cracks down on diversity and inclusion policies, studios are at a crossroads with some observers questioning how ...